Skip to main content

Peer Review reports

From: Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo

Original Submission
26 Aug 2013 Submitted Original manuscript
29 Aug 2013 Author responded Author comments - Alan Eastman
Resubmission - Version 2
29 Aug 2013 Submitted Manuscript version 2
2 Dec 2013 Author responded Author comments - Alan Eastman
20 Nov 2013 Reviewed Reviewer Report - Mark Meuth
22 Nov 2013 Reviewed Reviewer Report - Meredith Morgan
Resubmission - Version 3
2 Dec 2013 Submitted Manuscript version 3
Publishing
4 Dec 2013 Editorially accepted
21 Dec 2013 Article published 10.1186/1471-2407-13-604

You can find further information about peer review here.

Back to article page